{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:55:50Z","timestamp":1791186950183,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05671-2","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:27:09Z","timestamp":1787218029000},"page":"4873-4885","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone marrow fibrocytes and endothelial-to-mesenchymal transition drive pathological ECM remodeling in proliferative diabetic retinopathy"],"prefix":"10.1007","volume":"481","author":[{"given":"Ting-ting","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-peng","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"5671_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41572-025-00646-x","volume":"11","author":"S Sivaprasad","year":"2025","unstructured":"Sivaprasad S, Wong TY, Gardner TW et al (2025) Diabetic retinal disease. Nat Rev Dis Primers 11:62. https:\/\/doi.org\/10.1038\/s41572-025-00646-x","journal-title":"Nat Rev Dis Primers"},{"key":"5671_CR2","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.7150\/thno.83532","volume":"13","author":"M Xia","year":"2023","unstructured":"Xia M, Jiao L, Wang X-H et al (2023) Single-cell RNA sequencing reveals a unique pericyte type associated with capillary dysfunction. Theranostics 13:2515\u20132530. https:\/\/doi.org\/10.7150\/thno.83532","journal-title":"Theranostics"},{"key":"5671_CR3","doi-asserted-by":"publisher","first-page":"757607","DOI":"10.3389\/fimmu.2021.757607","volume":"12","author":"SK Boneva","year":"2021","unstructured":"Boneva SK, Wolf J, Hajd\u00fa RI et al (2021) In-depth molecular characterization of neovascular membranes suggests a role for hyalocyte-to-myofibroblast transdifferentiation in proliferative diabetic retinopathy. Front Immunol 12:757607. https:\/\/doi.org\/10.3389\/fimmu.2021.757607","journal-title":"Front Immunol"},{"key":"5671_CR4","doi-asserted-by":"publisher","first-page":"762","DOI":"10.2337\/db21-0551","volume":"71","author":"Z Hu","year":"2022","unstructured":"Hu Z, Mao X, Chen M et al (2022) Single-cell transcriptomics reveals novel role of microglia in fibrovascular membrane of proliferative diabetic retinopathy. Diabetes 71:762\u2013773. https:\/\/doi.org\/10.2337\/db21-0551","journal-title":"Diabetes"},{"key":"5671_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3109\/02713683.2012.720341","volume":"38","author":"K Coral","year":"2013","unstructured":"Coral K, Madhavan J, Pukhraj R, Angayarkanni N (2013) High glucose induced differential expression of lysyl oxidase and its isoform in ARPE-19 cells. Curr Eye Res 38:194\u2013203. https:\/\/doi.org\/10.3109\/02713683.2012.720341","journal-title":"Curr Eye Res"},{"key":"5671_CR6","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1167\/iovs.16-19798","volume":"57","author":"K Tamaki","year":"2016","unstructured":"Tamaki K, Usui-Ouchi A, Murakami A, Ebihara N (2016) Fibrocytes and fibrovascular membrane formation in proliferative diabetic retinopathy. Investig Opthalmology Vis Sci 57:4999. https:\/\/doi.org\/10.1167\/iovs.16-19798","journal-title":"Investig Opthalmology Vis Sci"},{"key":"5671_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.exer.2015.01.023","volume":"132","author":"AM Abu El-Asrar","year":"2015","unstructured":"Abu El-Asrar AM, De Hertogh G, Van Den Eynde K et al (2015) Myofibroblasts in proliferative diabetic retinopathy can originate from infiltrating fibrocytes and through endothelial-to-mesenchymal transition (EndoMT). Exp Eye Res 132:179\u2013189. https:\/\/doi.org\/10.1016\/j.exer.2015.01.023","journal-title":"Exp Eye Res"},{"key":"5671_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1167\/iovs.66.3.10","volume":"66","author":"D Liu","year":"2025","unstructured":"Liu D, Meng Z, Jin C et al (2025) Fibronectin mediates endothelial-to-mesenchymal transition in retina angiogenesis. Invest Ophthalmol Vis Sci 66:10. https:\/\/doi.org\/10.1167\/iovs.66.3.10","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5671_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41581-025-00969-8","volume":"21","author":"X Zhang","year":"2025","unstructured":"Zhang X, Zhang Y, Liu Y (2025) Fibroblast activation and heterogeneity in fibrotic disease. Nat Rev Nephrol 21:613\u2013632. https:\/\/doi.org\/10.1038\/s41581-025-00969-8","journal-title":"Nat Rev Nephrol"},{"key":"5671_CR10","doi-asserted-by":"publisher","first-page":"e172062","DOI":"10.1172\/jci.insight.172062","volume":"8","author":"K Corano Scheri","year":"2023","unstructured":"Corano Scheri K, Lavine JA, Tedeschi T et al (2023) Single-cell transcriptomics analysis of proliferative diabetic retinopathy fibrovascular membranes reveals AEBP1 as fibrogenesis modulator. JCI Insight 8:e172062. https:\/\/doi.org\/10.1172\/jci.insight.172062","journal-title":"JCI Insight"},{"key":"5671_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12951-026-04078-x","volume":"24","author":"X Teng","year":"2026","unstructured":"Teng X, Yuan Z, Li M et al (2026) Charge-flip nanoparticles loaded with TAK1 inhibitors inhibit retinal neovascularization. J Nanobiotechnol 24:199. https:\/\/doi.org\/10.1186\/s12951-026-04078-x","journal-title":"J Nanobiotechnol"},{"key":"5671_CR12","doi-asserted-by":"publisher","first-page":"eabm1896","DOI":"10.1126\/sciadv.abm1896","volume":"8","author":"Y Qin","year":"2022","unstructured":"Qin Y, Zhang J, Babapoor-Farrokhran S et al (2022) PAI-1 is a vascular cell-specific HIF-2-dependent angiogenic factor that promotes retinal neovascularization in diabetic patients. Sci Adv 8:eabm1896. https:\/\/doi.org\/10.1126\/sciadv.abm1896","journal-title":"Sci Adv"},{"key":"5671_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.7150\/ijbs.85735","volume":"20","author":"X Wu","year":"2024","unstructured":"Wu X, Qin B, Cheng R et al (2024) Angiogenic and fibrogenic dual-effect of Gremlin1 on proliferative diabetic retinopathy. Int J Biol Sci 20:897\u2013915. https:\/\/doi.org\/10.7150\/ijbs.85735","journal-title":"Int J Biol Sci"},{"key":"5671_CR14","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.3390\/cells10092443","volume":"10","author":"CJ Dalton","year":"2021","unstructured":"Dalton CJ, Lemmon CA (2021) Fibronectin: molecular structure, fibrillar structure and mechanochemical signaling. Cells 10:2443. https:\/\/doi.org\/10.3390\/cells10092443","journal-title":"Cells"},{"key":"5671_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/cells14020085","volume":"14","author":"AM Abu El-Asrar","year":"2025","unstructured":"Abu El-Asrar AM, Nawaz MI, Ahmad A et al (2025) ADAMTS13 improves endothelial function and reduces inflammation in diabetic retinopathy. Cells 14:85. https:\/\/doi.org\/10.3390\/cells14020085","journal-title":"Cells"},{"key":"5671_CR16","doi-asserted-by":"publisher","first-page":"118409","DOI":"10.1016\/j.biopha.2025.118409","volume":"190","author":"C Xu","year":"2025","unstructured":"Xu C, Meng Z, Lin W et al (2025) Semaglutide ameliorates retinal vascular permeability destruction in diabetic retinopathy by AnxA2-mediated MMP-9 activation and basement membrane remodeling. Biomed Pharmacother = Biomed Pharmacother 190:118409. https:\/\/doi.org\/10.1016\/j.biopha.2025.118409","journal-title":"Biomed Pharmacother = Biomed Pharmacother"},{"key":"5671_CR17","doi-asserted-by":"publisher","unstructured":"Saucedo L, Pfister IB, Zandi S et al (2021) Ocular TGF-\u03b2, matrix metalloproteinases, and TIMP-1 increase with the development and progression of diabetic retinopathy in type 2 diabetes mellitus. Mediators Inflammation 2021:9811361. https:\/\/doi.org\/10.1155\/2021\/9811361","DOI":"10.1155\/2021\/9811361"},{"key":"5671_CR18","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/bjo.84.10.1091","volume":"84","author":"J Salzmann","year":"2000","unstructured":"Salzmann J (2000) Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 84:1091\u20131096. https:\/\/doi.org\/10.1136\/bjo.84.10.1091","journal-title":"Br J Ophthalmol"},{"key":"5671_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-026-01581-4","author":"C Duveau","year":"2026","unstructured":"Duveau C, Raiss El Harrak Y, Datlibagi A et al (2026) Key role of transcription factors network in proliferative vitreoretinal diseases development. Cell Biosci. https:\/\/doi.org\/10.1186\/s13578-026-01581-4","journal-title":"Cell Biosci"},{"key":"5671_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41420-023-01545-4","volume":"9","author":"R Daley","year":"2023","unstructured":"Daley R, Maddipatla V, Ghosh S et al (2023) Aberrant Akt2 signaling in the RPE may contribute to retinal fibrosis process in diabetic retinopathy. Cell Death Discovery 9:243. https:\/\/doi.org\/10.1038\/s41420-023-01545-4","journal-title":"Cell Death Discovery"},{"key":"5671_CR21","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.3390\/ijms23095088","volume":"23","author":"PC Trackman","year":"2022","unstructured":"Trackman PC, Peymanfar Y, Roy S (2022) Functions and mechanisms of Pro-Lysyl oxidase processing in cancers and eye pathologies with a focus on diabetic retinopathy. Int J Mol Sci 23:5088. https:\/\/doi.org\/10.3390\/ijms23095088","journal-title":"Int J Mol Sci"},{"key":"5671_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2337\/db25-0541","volume":"75","author":"M Agarwal","year":"2026","unstructured":"Agarwal M, Chandrakumar S, Santiago Tierno I et al (2026) Lysyl oxidase promotes actin-dependent neutrophil activation and cytotoxicity toward retinal endothelial cells in diabetes. Diabetes 75:166\u2013179. https:\/\/doi.org\/10.2337\/db25-0541","journal-title":"Diabetes"},{"key":"5671_CR23","doi-asserted-by":"publisher","first-page":"11378","DOI":"10.3390\/ijms231911378","volume":"23","author":"S Zaffryar-Eilot","year":"2022","unstructured":"Zaffryar-Eilot S, Hasson P (2022) Lysyl oxidases: Orchestrators of cellular behavior and ECM remodeling and homeostasis. Int J Mol Sci 23:11378. https:\/\/doi.org\/10.3390\/ijms231911378","journal-title":"Int J Mol Sci"},{"key":"5671_CR24","doi-asserted-by":"publisher","first-page":"18810","DOI":"10.1038\/s41598-021-97970-5","volume":"11","author":"A Korhonen","year":"2021","unstructured":"Korhonen A, Gucciardo E, Lehti K, Loukovaara S (2021) Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement. Sci Rep 11:18810. https:\/\/doi.org\/10.1038\/s41598-021-97970-5","journal-title":"Sci Rep"},{"key":"5671_CR25","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.3390\/ijms23084256","volume":"23","author":"M Caban","year":"2022","unstructured":"Caban M, Owczarek K, Lewandowska U (2022) The role of metalloproteinases and their tissue inhibitors on ocular diseases: Focusing on potential mechanisms. Int J Mol Sci 23:4256. https:\/\/doi.org\/10.3390\/ijms23084256","journal-title":"Int J Mol Sci"},{"key":"5671_CR26","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.apsb.2025.02.007","volume":"15","author":"L Guo","year":"2025","unstructured":"Guo L, Xiang W, Pan Z et al (2025) Post-translational modifications of collagen and its related diseases in metabolic pathways. Acta Pharm Sin B 15:1773\u20131795. https:\/\/doi.org\/10.1016\/j.apsb.2025.02.007","journal-title":"Acta Pharm Sin B"},{"key":"5671_CR27","doi-asserted-by":"publisher","first-page":"e36111","DOI":"10.1016\/j.heliyon.2024.e36111","volume":"10","author":"M Fu","year":"2024","unstructured":"Fu M, Zhengran L, Yingli L et al (2024) The contribution of adiponectin to diabetic retinopathy progression: Association with the AGEs-RAGE pathway. Heliyon 10:e36111. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36111","journal-title":"Heliyon"},{"key":"5671_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.33176\/AACB-20-0001","volume":"42","author":"MJ Gillett","year":"2021","unstructured":"Gillett MJ, Vasikaran SD, Inderjeeth CA (2021) The role of PINP in diagnosis and management of metabolic bone disease. Clin Biochem Rev 42:3\u201310. https:\/\/doi.org\/10.33176\/AACB-20-0001","journal-title":"Clin Biochem Rev"},{"key":"5671_CR29","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.nut.2015.06.012","volume":"31","author":"M Ogata","year":"2015","unstructured":"Ogata M, Ide R, Takizawa M et al (2015) Association between basal metabolic function and bone metabolism in postmenopausal women with type 2 diabetes. Nutrition 31:1394\u20131401. https:\/\/doi.org\/10.1016\/j.nut.2015.06.012","journal-title":"Nutrition"},{"key":"5671_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.amjms.2017.07.003","volume":"354","author":"X Zhang","year":"2017","unstructured":"Zhang X, Yang J, Zhong Y et al (2017) Association of bone metabolic markers with diabetic retinopathy and diabetic macular edema in elderly Chinese individuals with type 2 diabetes mellitus. Am J Med Sci 354:355\u2013361. https:\/\/doi.org\/10.1016\/j.amjms.2017.07.003","journal-title":"Am J Med Sci"},{"key":"5671_CR31","doi-asserted-by":"publisher","unstructured":"Zhao X, Huo L, Yu X, Zhang X (2021) Association of bone metabolism indices and bone mineral density with diabetic retinopathy in elderly patients with type 2 diabetes mellitus: a cross-sectional inpatient study in China. J Diabetes Res 2021(8853622). https:\/\/doi.org\/10.1155\/2021\/8853622","DOI":"10.1155\/2021\/8853622"},{"key":"5671_CR32","doi-asserted-by":"publisher","first-page":"10004","DOI":"10.3390\/ijms241210004","volume":"24","author":"H Devos","year":"2023","unstructured":"Devos H, Zoidakis J, Roubelakis MG et al (2023) Reviewing the regulators of COL1A1. Int J Mol Sci 24:10004. https:\/\/doi.org\/10.3390\/ijms241210004","journal-title":"Int J Mol Sci"},{"key":"5671_CR33","doi-asserted-by":"publisher","first-page":"112259","DOI":"10.1016\/j.cellsig.2025.112259","volume":"138","author":"X Ji","year":"2026","unstructured":"Ji X, Yun Y, Zhu Z et al (2026) COL1A1 promotes clear cell renal cell carcinoma progression through the wnt\/\u03b2-catenin signaling pathway. Cell Signal 138:112259. https:\/\/doi.org\/10.1016\/j.cellsig.2025.112259","journal-title":"Cell Signal"},{"key":"5671_CR34","doi-asserted-by":"publisher","first-page":"105436","DOI":"10.1016\/j.phrs.2021.105436","volume":"165","author":"G Lin","year":"2021","unstructured":"Lin G, Wan X, Liu D et al (2021) COL1A1 as a potential new biomarker and therapeutic target for type 2 diabetes. Pharmacol Res 165:105436. https:\/\/doi.org\/10.1016\/j.phrs.2021.105436","journal-title":"Pharmacol Res"},{"key":"5671_CR35","doi-asserted-by":"publisher","first-page":"e25166","DOI":"10.1016\/j.heliyon.2024.e25166","volume":"10","author":"G Zou","year":"2024","unstructured":"Zou G, Que L, Liu Y, Lu Q (2024) Interplay of endothelial-mesenchymal transition, inflammation, and autophagy in proliferative diabetic retinopathy pathogenesis. Heliyon 10:e25166. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e25166","journal-title":"Heliyon"},{"key":"5671_CR36","doi-asserted-by":"publisher","first-page":"1230581","DOI":"10.3389\/fopht.2023.1230581","volume":"3","author":"W Nijim","year":"2023","unstructured":"Nijim W, Moustafa M, Humble J, Al-Shabrawey M (2023) Endothelial to mesenchymal cell transition in diabetic retinopathy: targets and therapeutics. Front Ophthalmol 3:1230581. https:\/\/doi.org\/10.3389\/fopht.2023.1230581","journal-title":"Front Ophthalmol"},{"key":"5671_CR39","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1124\/pharmrev.121.000349","volume":"74","author":"LGN de Almeida","year":"2022","unstructured":"de Almeida LGN, Thode H, Eslambolchi Y et al (2022) Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology. Pharmacol Rev 74:712\u2013768. https:\/\/doi.org\/10.1124\/pharmrev.121.000349","journal-title":"Pharmacol Rev"},{"key":"5671_CR40","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1167\/iovs.02-0662","volume":"44","author":"K Noda","year":"2003","unstructured":"Noda K, Ishida S, Inoue M et al (2003) Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 44:2163. https:\/\/doi.org\/10.1167\/iovs.02-0662","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5671_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1755-3768.2009.01701.x","volume":"89","author":"C Symeonidis","year":"2011","unstructured":"Symeonidis C, Papakonstantinou E, Souliou E et al (2011) Correlation of matrix metalloproteinase levels with the grade of proliferative vitreoretinopathy in the subretinal fluid and vitreous during rhegmatogenous retinal detachment. Acta Ophthalmol (copenh) 89:339\u2013345. https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01701.x","journal-title":"Acta Ophthalmol (copenh)"},{"key":"5671_CR42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41569-024-01103-0","volume":"22","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhou J, Kong W (2025) Extracellular matrix in vascular homeostasis and disease. Nat Rev Cardiol 22:333\u2013353. https:\/\/doi.org\/10.1038\/s41569-024-01103-0","journal-title":"Nat Rev Cardiol"},{"key":"5671_CR43","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1167\/iovs.07-1550","volume":"49","author":"K Coral","year":"2008","unstructured":"Coral K, Angayarkanni N, Madhavan J et al (2008) Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachment. Invest Ophthalmol Visual Sci 49:4746\u20134752. https:\/\/doi.org\/10.1167\/iovs.07-1550","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"5671_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1167\/iovs.61.4.40","volume":"61","author":"N-H Nguyen","year":"2020","unstructured":"Nguyen N-H, Kim D, Roy S (2020) High glucose increases binding of lysyl oxidase to extracellular matrix proteins: Implications for diabetic retinopathy. Invest Ophthalmol Visual Sci 61:40. https:\/\/doi.org\/10.1167\/iovs.61.4.40","journal-title":"Invest Ophthalmol Visual Sci"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05671-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05671-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05671-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:45:12Z","timestamp":1791186312000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05671-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":42,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5671"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05671-2","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out following the Declaration of Helsinki and received approval from the Ethics Committee of the First People\u2019s Hospital of Jiujiang City, Jiangxi Province, China (Approval number : JJSDYRMYY-YXLL-2025-112; Approval date: April 1, 2025).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}